Zhongzhi Pharmaceutical Holdings logo

3737 - Zhongzhi Pharmaceutical Holdings News Story

HK$1.4 0.0  0.0%

Last Trade - 7:01am

Sector
Consumer Defensives
Size
Small Cap
Market Cap £108.3m
Enterprise Value £96.8m
Revenue £176.2m
Position in Universe 3155th / 6091

BRIEF-Zhongzhi Pharmaceutical Posts HY Profit Attributable Of RMB47 Mln

Wed 29th August, 2018 4:03pm
Aug 29 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
 3737.HK :
    * HY REVENUE RMB556.7 MILLION VERSUS RMB431.5 MILLION
    * HY PROFIT ATTRIBUTABLE RMB47 MILLION VERSUS RMB38.5
MILLION
    * RECOMMENDS INTERIM DIVIDEND OF HK2.65 CENTS PER SHARE & A
SPECIAL DIVIDEND OF HK1.70 CENTS PER SHARE

Source text for Eikon:  ID:nHKS9Z1L6g 
Further company coverage:  3737.HK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.